News on Mesothelioma | Surviving Mesothelioma

Immunotherapy and Radiation: A Powerful Mesothelioma Combo

New research suggests that, in the battle against malignant pleural mesothelioma, a treatment combining of immunotherapy drugs with radiotherapy may be a powerful new weapon. Researchers at the University of Pennsylvania reached that conclusion after reviewing the few existing studies on this emerging multimodal mesothelioma treatment for an article in Translational Lung Cancer Research.   Current available treatments for pleural mesothelioma, an aggressive lung-related cancer,  include surgical resection, … Continue reading Immunotherapy and Radiation: A Powerful Mesothelioma Combo »

Predicting Mesothelioma Outcomes with Soluble Mesothelin

New research suggests that a protein often used to help diagnose and track malignant mesothelioma may also be a valuable prognostic indicator. Soluble mesothelin-related protein (SMRP) is a biomarker for pleural mesothelioma, an aggressive asbestos-linked cancer that causes few symptoms until in its late stages. The presence of SMRP in the blood indicates that mesothelial cells on the lining around the lungs have been damaged. … Continue reading Predicting Mesothelioma Outcomes with Soluble Mesothelin »

Mesothelioma Risk and the Timing of Asbestos Exposure

The timing of a person’s exposure to asbestos may play a bigger role in the development of malignant pleural mesothelioma than previously thought. A new French study has found that asbestos exposure earlier in a worker’s career appeared to raise their risk of developing pleural mesothelioma more than asbestos exposure later in their work life. Exposure Timing and Mesothelioma Risk The study evaluated the cases … Continue reading Mesothelioma Risk and the Timing of Asbestos Exposure »

Mesothelioma Risk in the Families of Asbestos-Exposed Workers

A new Italian study is a sobering reminder that living with someone who has worked around asbestos can have fatal consequences. Researchers examined the cases of 33 women and 2 men with malignant mesothelioma whose only known exposure to asbestos was through a family member – usually a husband or father – with a history of occupational asbestos exposure. Like asbestos-exposed workers, these family members were … Continue reading Mesothelioma Risk in the Families of Asbestos-Exposed Workers »

IMRT Beats Conformal Radiotherapy for Pleural Mesothelioma

The targeted radiotherapy technique known as intensity-modulated radiotherapy (IMRT) may offer a safer way to treat pleural mesothelioma tumors with fewer side effects. Researchers at Gazi University in Ankara, Turkey recently compared the outcomes of  twenty-four radiation therapy plannings in patients with malignant pleural mesothelioma and found that IMRT was both less dangerous and more effective. Radiotherapy for Mesothelioma Radiotherapy is often used in pleural … Continue reading IMRT Beats Conformal Radiotherapy for Pleural Mesothelioma »

Retreatment with Alimta Leads to 4+ Year Survival for Peritoneal Mesothelioma Patient

geriatrics

There is new evidence that re-treatment with Alimta (pemetrexed) can significantly prolong survival for people with peritoneal mesothelioma, even after their cancer has come back. Cancer researchers in Zagreb, Croatia recently published the case report of a 45-year-old patient who lived for more than four years after a diagnosis of advanced peritoneal mesothelioma. His doctors credit his survival to cytoreductive surgery, intraperitoneal chemotherapy, and several … Continue reading Retreatment with Alimta Leads to 4+ Year Survival for Peritoneal Mesothelioma Patient »

New Report May Fuel Debate Over Mesothelioma Surgery

A new Swiss report on the two major types of mesothelioma surgery appears to raise as many questions as it answers, adding fuel to the fire in the ongoing debate over surgical technique. While thoracic surgeons around the world remain divided over the best type of surgery for the asbestos cancer,  the report suggests that the two primary curative approaches have similar rates of complications … Continue reading New Report May Fuel Debate Over Mesothelioma Surgery »

VEGF-Inhibitor Looks Promising for Malignant Mesothelioma

There is more encouraging news about the monoclonal antibody bevacizumab (Avastin) and its potential to boost the effectiveness of chemotherapy for people with malignant pleural mesothelioma. A pair of oncology researchers from Texas have just released their summary of the the most recent published studies on bevacizumab. They conclude that, for the right patients, bevacizumab may improve mesothelioma outcomes and extend survival by blocking tumor blood … Continue reading VEGF-Inhibitor Looks Promising for Malignant Mesothelioma »

Doll Making Linked to Pleural Mesothelioma

People who worked in factories that produced cloth dolls may have to be added to the list of people at risk of developing deadly malignant pleural mesothelioma. A new Italian study is the second study to draw a link between cases of the lung-related asbestos cancer and doll manufacturing. Asbestos-Related Diseases and Dollmaking The new study utilized data from the Province of Brescia Mesothelioma Registry, … Continue reading Doll Making Linked to Pleural Mesothelioma »

Additional Chemotherapy Extends Survival in Relapsed Mesothelioma Patients

Black American Patient

Mesothelioma patients who experience a recurrence of their asbestos cancer after radical surgery may live longer if they undergo additional rounds of chemotherapy. That conclusion comes from a group of Japanese researchers who performed a retrospective review of 59 consecutive pleural mesothelioma patients who had multimodal mesothelioma treatment that included extrapleural pneumonectomy (EPP) surgery. Study subjects had been treated for malignant mesothelioma at Hyogo College … Continue reading Additional Chemotherapy Extends Survival in Relapsed Mesothelioma Patients »

Get your free copy of
“Surviving Mesothelioma” Today!